Skip to main content
. 2021 Dec 9;21:559. doi: 10.1186/s12887-021-03036-w

Table 1.

General characteristics

noPDA (n = 64) PDA (n = 41) HsPDA (n = 18) p value
Gestational age (weeks), mean (SD)1–3 28.5 (1.92) 27.2 (1.65) 25.8 (2.01) < 0.001
Birth weight (g), mean (SD)1–3 1118.6 (221.03) 1009.5 (215.43) 839.4 (219.99) < 0.001
Male, % 31 (48.4) 23 (56.1) 10 (55.6) NS
Apgar at 1 min, mean (SD) 7 (1.62) 6.7 (1.82) 5.8 (2.28) NS
Apgar at 5 min, mean (SD) 8 (1.41) 7.9 (1.19) 7.4 (1.33) NS
Hours of life at measurement, mean (SD)2, 3 150.4 (45.3) 141.6 (36.7) 185.8 (58.0) 0.003
Haematocrit (%), mean (SD)2 46.03 (8.48) 43.67 (10.523) 38.71 (7.094) 0.011
Platelets (× 109/l), mean (SD) 269.19 (99.687) 254 (116.908) 258.44 (150.983) NS
pCO2, mean (SD) 42.25 (6.816) 44.41 (9.25) 46.09 (10.912) NS
Lactate (mmol/l), mean (SD) 1.94 (0.598) 2.15 (1.084) 2.06 (0.523) NS
Urine output (ml/kg/h), mean (SD) 3.91 (0.796) 3.63 (0.971) 3.51 (0.899) NS
Antenatal steroids 2x, % 42 (66.7) 32 (78.0) 13 (72.2) NS
Chorioamnionitis, % 16 (25.8) 11 (28.9) 6 (35.3) NS
Caesarean section, % 44 (68.8) 33 (80.5) 8 (44.4) 0.025
Surfactant, % 41 (64.1) 36 (87.8) 17 (94.4) 0.003
Mechanical ventilation, % 11 (17.2) 18 (43.9) 16 (88.9) < 0.001
Non-invasive respiratory support, % 35 (54.7) 17 (41.5) 1 (5.6) < 0.001
FiO2, mean (SD)2, 3 0.25 (0.05) 0.25 (0.05) 0.32 (0.09) < 0.001
Ductus diameter (cm), mean (SD)3 0.17 (0.039) 0.26 (0.032) < 0.001
LA/Ao ratio, mean (SD)1–3 1.24 (0.174) 1.38 (0.202) 1.72 (0.179) < 0.001
RI ACA, mean (SD)1–3 0.7 (0.039) 0.74(0.061) 0.84 (0.144) < 0.001
CROR, mean (SD)1, 2 0.97 (0.091) 0.90 (0.108) 0.87 (0.167) 0.001

1: Statistically significant difference between the “noPDA” and “PDA” groups

2: Statistically significant difference between the “noPDA” and “HsPDA” groups

3: Statistically significant difference between the “PDA” and “HsPDA” groups. NS: not significant